Antimicrobial agents play a pivotal role in combating infectious diseases, offering a crucial line of defense against harmful microorganisms. Antibiotics, in particular, are substances derived from living organisms or synthesized chemically, designed to inhibit the growth of bacteria or destroy them altogether. They target specific cellular components or processes, disrupting bacterial functions without harming human cells. In the realm of antiviral agents, drugs like protease inhibitors and nucleoside analogs thwart the replication of viruses by targeting key enzymes. Antifungal agents, on the other hand, combat fungal infections by disrupting cell membrane synthesis or inhibiting essential enzymes. Parasitic infections are addressed through antiparasitic agents, targeting specific metabolic pathways in parasites. The emergence of antimicrobial resistance poses a significant challenge, urging the continuous exploration of novel agents and alternative therapeutic strategies. Research in this field focuses on developing innovative antimicrobial compounds, exploring combination therapies, and understanding the mechanisms behind resistance.
Title : Diagnostic approaches, predictive and prognostic assessments, monitoring, treatment & management of infectious diseases and disease prevention
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The accelerated timeline: Human ecology, climate change, and the next global outbreak
Claudia Ferreira, Sorbonne University, France
Title : Climate change and increasing death due to resistant infection
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Recurrent klebsiella pneumoniae pyogenic liver abscess: Developing a literature-informed 0–2 scoring framework from a solved index case
Martha Grace McLean, Anne Burnett Marion School of Medicine at Texas Christian University, United States
Title : Post-hysterectomy pelvic abscess mimic: An AI-assisted diagnostic stewardship workflow
Setu Shiroya, Anne Burnett Marion School of Medicine at Texas Christian University, United States
Title : Building a clinical reasoning tool from post-transplant MRSA sepsis: A mentored ai workflow
Michaela Mitchell, Anne Burnett Marion School of Medicine at Texas Christian University, United States